InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Meyers Michael L., Vice-Président Senior, Directeur Médical. Director active across 2 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 6 reports have been published. History available since 30 December 2021. The latest transaction was filed on 15 July 2026 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Meyers Michael L. is Senior Vice President, Chief Medical Officer. He is linked to Nuvalent, Inc. as Director and to Syndax Pharmaceuticals Inc as SVP, Chief Medical Officer, and his 6 filings cover recent filings from 2022-01-03 to 2026-07-15, with Attribution as the transaction nature in the sampled items.